ArchivesMagazine - 18 Sep 2025Hikma Pharmaceuticals shares plumb new 20-month lows In June Hikma announced a $1 billion investment in the US to expand its domestic manufacturing of generic medicines 18 September 2025|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < The IPO market is showing signs of life in both the UK and US Airtel Africa is one of the big surprise success stories of 2025 > Issue: 18 Sep 2025 - Page 8 | Contents Next: Airtel Africa is one of the big surprise success stories of 2025 Previous: The IPO market is showing signs of life in both the UK and US Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Rachel How will the chancellor’s inheritance tax plans affect my pension wishes? Editor's View Gold takes out inflation-adjusted high as central banks look set to keep buying Feature Our fund selection Are we about to see a resurgence of bad loans as the US economy slows? Great Ideas Buy Rightmove for its resilient earnings growth Johnson Service Group looks cheap for the quality of the business How Oracle investors can strike a risk reward balance after 82% share price surge News Category killer Costco needs to deliver the goods next week The IPO market is showing signs of life in both the UK and US Strategic Equity Capital offers investors their money back via tender offer Airtel Africa is one of the big surprise success stories of 2025 Hikma Pharmaceuticals shares plumb new 20-month lows Personal Finance What are the costs and benefits of retiring early? Russ Mould Is it time for some heavy metal? Week Ahead Why Kingfisher shares are under the hammer
